abstracted & translated by
Bob Flaws,
L.Ac.
On page 332 of issue5, 2009 of Zhe Jiang Zhong Yi Za
Zhi (Zhejiang Journal of Chinese Medicine), Hong Miao-lan published an article
titled, “The Treatment of 60 Cases of Endometriosis with Wen Jing Tang.” A
summary of this article is presented below.
Cohort
description:
Altogether, there were 110 cases of endometriosis
enrolled in this two-wing comparison study. These 110 cases were randomly
divided into a treatment group of 60 cases and a comparison group of 50 cases.
In the treatment group, the median age was 28.3 plus/minus 4.8 years, sixteen
of these cases suffered mild dysmenorrhea, 28 cases suffered moderate
dysmenorrhea, and sixteen cases suffered severe dysmenorrhea. There were 48
cases of infertility, 25 cases of dyspareunia, and 30 cases of menstrual period
low back pain. In 35 cases, ultrasound and gynecological examination confirmed
the presence of adnexal pressure pain and chocolate cysts. In the comparison
group, the median age was 27.7 plus/minus 5.1 years. Fourteen of these cases
had mild dysmenorrhea, 24 had moderate dysmenorrhea, and 12 cases had severe
dysmenorrhea. There were also 38 cases of infertility, 30 cases of dyspareunia,
and 40 cases of menstrual period low back pain. In this group, ultrasound and
gynecological examination revealed 30 cases of adnexal pressure pain and
chocolate cysts. Therefore, these two groups were deemed statistically
comparable for the purposes of this study.
Treatment method:
Beginning on the first day of the menstrual cycle,
both groups received 12.5 milligrams of mifepristone per day for a continuous three months. In addition, members of the treatment
group also received the following version of Wen Jing Tang (Warm the Menses
Decoction):
Dang Shen (Radix Codonopsis)
Bai Shao (Radix Alba Paeoniae), 15g each
Dang Gui (Radix Angelicae Sinensis), 30g
Chuan Xiong (Rhizoma Chuanxiong)
Rou Gui (Cortex Cinnamomi)
Mu Dan Pi (Cortex
Moutan)
mix-fried Gan Cao (Radix Glycyrrhizae), 10g each
E Zhu (Rhizoma Zedoariae)
Niu Xi (Radix Achyranthis Bidentatae), 12g each
Modifications:
If inflammation and symptoms of blood stasis were
relatively severe, Xia Ku Cao (Spica Prunellae), Yi Mu Cao (Herba Leonuri), San
Leng (Rhizoma Sparganii), and Zao Jiao Ci (Spina Gleditsiae) were added.
If low back pain was severe, Wu Ling Zhi (Faeces
Trogpterori), Shui Zhi (Hirudo), and Pu Huang (Pollen Typhae) were added.
If there was liver depression qi stagnation, Zhi Ke
(Fructus Aurantii) and Xiang Fu (Rhizoma Cyperi) were added.
One packet of these medicinals per day was decocted
in water two times to achieve 200 milliliters of medicinal liquid. This liquid
was divided into two doses and one dose was administered in the morning and the
other in the evening each day. This regime was continued for three months.
Study outcomes:
Cure was defined as complete disappearance of
symptoms as well as lumps in the pelvic cavity. In addition, if the patient had
been infertile, she conceived and gave birth within two years. Marked effect
was defined as basic disappearance of symptoms, shrinkage of pelvic lumps, and
at least conception if the patient had been infertile. Some effect was defined
as a decrease in symptoms, a slight decrease or at least no growth in pelvic
lumps, and no worsening of symptoms within three months of stopping medication.
No effect meant that there was no change in the main symptoms or that some of the
symptoms got worse. The following table shows the outcomes in the two groups
based on these criteria.
|
Group
|
Number
|
Cured
|
Marked effect
|
Some effect
|
No effect
|
Total effective-ness
|
|
Treatment
|
60
|
28 cases (46.67%)
|
17 cases (28.33%)
|
11 cases (18.33%)
|
4 cases (6.67%)
|
93.33%
|
|
Comparison
|
50
|
10 cases (20.00%)
|
12 cases (24.00%)
|
13 cases (26.00%)
|
15 cases (30.00%)
|
70.00%
|
Thus, this study showed that the combination of Wen
Jing Tang with mifepristone was markedly more effective than mifepristone alone
in the treatment of endometriosis. In the treatment group, six cases
experienced recurrence, while 29 out of the 48 cases of infertility (60%)
conceived. In the comparison group, 11 cases experienced recurrence and only 15
of the 38 cases of infertility (39%) conceived. Therefore, the recidivism rate
was considerably less and the conception rate was markedly higher in the
treatment group. There were no obvious signs of liver or kidney function
impairment or other adverse reactions in either group.
Discussion:
According to Dr. Hong, blood stasis is the main
disease mechanism of endometriosis in terms of Chinese medicine. Therefore, the
treatment principles on which this study was based were to quicken the blood
and dispel stasis. Wen Jing Tang originally comes from Chen Zi-ming’s famous
Song dynasty Fu Ren Liang Fang Da Chuan
(Great Collection of Fine Formulas for Women). Within it, Dr. Hong says
Dang Shen, Dang Gui, Chuan Xiong, and Shao Yao supplement and move the blood.
Thus there is supplementation without stagnation and moving within
supplementation. Dr. Hong thinks this is important because women commonly
suffer from blood vacuity, and this vacuity easily leads to blood stasis. Hence
this formula supports the righteous and dispels evils at the same time. Rou Gui
warms the menses and scatters cold. E Zhu, Mu
Dan Pi, and Niu Xi quicken the blood and move stagnation. As a combination, Bai
Shao and Gan Cao relax cramping and stop pain. These two medicinals form the
famous formula Sha Yao Gan Cao Tang (Peony & Licorice Decoction) from Zhang
Zhong-jing’s late Han dynasty Shang Han
Lun (Treatise on Damage [Due to] Cold). Dr. Hong believes that, when the
above medicinals are used together, they are an effective prescription for the
treatment of cold congelation and blood stasis in the uterus resulting in
menstrual pain and infertility.
Endnote:
. Mifepristone is a synthetic steroid compound used as a
pharmaceutical. It is used as an abortifacient in the first two months of
pregnancy, and in smaller doses as an emergency contraceptive. During early
trials, it was known as RU-486. Other medical applications of mifepristone that
have been studied in phase II clinical trials include regular long-term use as
an oral contraceptive and treatment of uterine fibroids, endometriosis, major
depression with psychotic features, glaucoma, meningiomas, breast cancer,
ovarian cancer, prostate cancer, and some types of Cushing's syndrome.
Copyright © Blue
Poppy Press, 2009. All rights reserved.